[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$ftmQAXpRaJiNCihGg95OMcTDNnxZJYYCRyMq6AMMia9Y":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":32,"phaseBuckets":38,"rows":45},"Heart and Diabetes Center North-Rhine Westfalia",[4],33,false,5,1,14079,29,[13,16,19,22,24,26,28,30],{"name":14,"count":15},"Heart Failure",8,{"name":17,"count":18},"Atrial Fibrillation",4,{"name":20,"count":21},"Congestive Heart Failure",2,{"name":23,"count":21},"Cardiac Resynchronization Therapy",{"name":25,"count":21},"Heart Transplantation",{"name":27,"count":21},"Obesity",{"name":29,"count":21},"Tricuspid Regurgitation",{"name":31,"count":21},"Cardiovascular Disease",[33],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06556485","Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure","2026-06-01","Medical therapy",[39,40,41,42,43,44],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[46,73,98,124],{"intervention":37,"totalTrials":9,"cells":47},{"EARLY_PHASE1":48,"PHASE1":51,"PHASE2":53,"PHASE3":55,"PHASE4":57,"NA":59},{"trials":49,"activeCount":50},[],0,{"trials":52,"activeCount":50},[],{"trials":54,"activeCount":50},[],{"trials":56,"activeCount":50},[],{"trials":58,"activeCount":50},[],{"trials":60,"activeCount":9,"soonestReadout":36},[61],{"nctId":34,"briefTitle":35,"status":62,"phases":63,"primaryCompletion":36,"completion":64,"start":65,"enrollment":66,"conditions":67,"interventions":72},"RECRUITING",[44],"2027-01-01","2024-09-13",160,[14,68,69,70,25,71],"Arrhythmia, Ventricular","Cardiomyopathy Ischemic","Catheter Ablation","Left Ventricular Assist Device",[37],{"intervention":74,"totalTrials":9,"cells":75},"Vitamin D",{"EARLY_PHASE1":76,"PHASE1":78,"PHASE2":80,"PHASE3":82,"PHASE4":84,"NA":96},{"trials":77,"activeCount":50},[],{"trials":79,"activeCount":50},[],{"trials":81,"activeCount":50},[],{"trials":83,"activeCount":50},[],{"trials":85,"activeCount":50},[86],{"nctId":87,"briefTitle":88,"status":89,"phases":90,"primaryCompletion":91,"completion":91,"start":92,"enrollment":93,"conditions":94,"interventions":95},"NCT01326650","Vitamin D and Mortality in Heart Failure","COMPLETED",[43],"2016-07","2010-11",400,[20],[74],{"trials":97,"activeCount":50},[],{"intervention":99,"totalTrials":9,"cells":100},"phenprocoumon",{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":122},{"trials":102,"activeCount":50},[],{"trials":104,"activeCount":50},[],{"trials":106,"activeCount":50},[],{"trials":108,"activeCount":50},[],{"trials":110,"activeCount":50},[111],{"nctId":112,"briefTitle":113,"status":114,"phases":115,"primaryCompletion":116,"completion":116,"start":117,"enrollment":118,"conditions":119,"interventions":121},"NCT00528671","Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications","TERMINATED",[43],"2013-11","2006-01",1571,[120],"Mechanical Heart Valve Recipients",[99,99,99],{"trials":123,"activeCount":50},[],{"intervention":125,"totalTrials":9,"cells":126},"Oxygen",{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":145,"NA":147},{"trials":128,"activeCount":50},[],{"trials":130,"activeCount":50},[],{"trials":132,"activeCount":50},[],{"trials":134,"activeCount":50},[135],{"nctId":136,"briefTitle":137,"status":114,"phases":138,"primaryCompletion":139,"completion":139,"start":140,"enrollment":141,"conditions":142,"interventions":144},"NCT03102827","High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure",[42],"2018-03-27","2017-02-02",14,[143],"Heart Failure，Congestive",[125],{"trials":146,"activeCount":50},[],{"trials":148,"activeCount":50},[]]